The Spain's largest
pharmaceutical company, Grifols, became
one of the first executives of a major corporation to back a
Catalan leader seeking a referendum on independence for
The head of Barcelona-based Grifols, Victor Grifols, held up his company's history - growing from a small, family-owned business into the
world's third-largest maker of blood plasma products - as an
example for Artur Mas.
Grifols was founded in 1940 Josep Grifols Roig, a hematologist
and scientist. He was the first researcher to publish the
plasmapheresis procedure in 1951. The company introduced its liquid IVIG
product into the European market in the mid-1990s. In 2003 the company
acquired certain assets of the LA -based Alpha Therapeutic as the basis of its American expansion.
On 2011, a year after announcing the $4 billion deal, Grifols
completed a takeover of Talecris Biotherapeutics, headquartered in North Carolina. Grifols acquired the blood transfusion diagnostics unit from Novartis in 2013 as a "platform for global expansion".
During a speech at the inauguration of a plant outside
Barcelona, on Tuesday, Chairman Victor Grifols turned to Catalonia's president Artur Mas, who was
attending the opening.
"A company that is determined must not question that
determination," Grifols said. "I know you're having a rough
time, but if you are determined, keep pushing forward and don't
Besides Grifols, Barcelona is home to some of Spain's
biggest companies, including its third-biggest bank, Caixabank
and smaller peer Sabadell, the global
infrastructure company Abertis and the utility Gas